Dr. Eric Topol on Variants, Vaccines and AstraZeneca’s Data Reporting

MONDAY, MARCH 22, 2021
This week Mark and Margaret speak with Dr. Eric Topol, Director of the Scripps Research Translational Institute. Dr. Topol calls drug maker AstraZeneca’s recent controversial under-reporting of complete safety data to US regulators for its COVID-19 vaccine ‘disturbing’ and ‘unprecedented’ in his clinical trial career. He calls the rapid development of highly successful and effective COVID vaccines one of biomedicine’s greatest achievements and predicts the pandemic crisis will pave the way for more remarkable scientific breakthroughs, and a greater opportunity for the growth of personalized medicine via smartphones.

To download a full transcript of this episode, click here.

To download audio file, click here.

More Like This
New Research Bolsters Model for Preventing Infant Mortality  Image
New Research Bolsters Model for Preventing Infant Mortality
Preventing Veteran Suicides: Strategies & Tactics Image
Preventing Veteran Suicides: Strategies & Tactics
Government Shutdown Stalls Drug Discount Program 340B Image
Government Shutdown Stalls Drug Discount Program 340B